{"id":47228,"date":"2022-08-12T07:02:07","date_gmt":"2022-08-12T05:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/"},"modified":"2022-08-12T07:02:07","modified_gmt":"2022-08-12T05:02:07","slug":"disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/","title":{"rendered":"Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku"},"content":{"rendered":"
\n

TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp<\/a>, Toei Shinyaku has disclosed data concerning the mechanism by which Agaricus blazei<\/i> KA21 enhances immunity, its immunological enhancement effect as confirmed by human clinical trials, and candida and other types of fungal infection. Agaricus blazei<\/i> KA21 product has been sold in the Japanese market as a supplement for the immune system for more than 25 years, and has won the support of many physicians.\n<\/p>\n

<\/a><\/p>\n

\nAbout Agaricus blazei<\/i>, brasiliensis<\/i>, subrufescens<\/i><\/b>\n<\/p>\n

\nAgaricus blazei<\/i> (also known as Agaricus blazei<\/i> Murill, A. brasiliensis<\/i>, A. subrufescens<\/i>) is a medicinal mushroom. It is popular primarily in Asian countries (particularly Japan) as an ingredient of immune booster used in complementary and alternative medicine (CAM). Characteristics of Agaricus blazei<\/i> such as safety and effectiveness vary significantly depending on the strain, cultivation method, and production region.\n<\/p>\n

\nAgaricus KA21 (Common name: King Agaricus)<\/b>\n<\/p>\n

\nAgaricus KA21 is Agaricus blazei<\/i> KA21 strain cultivated outdoors in Brazil under direct sunlight. Compared to regular Agaricus blazei<\/i> cultivated in a dark greenhouse, Agaricus KA21 is large in size, contains an abundance of major ingredients such as beta-glucan and vitamin D, and offers an antioxidant activity level over five times greater. Outdoor cultivation is extremely difficult with small yield, therefore Agaricus KA21 is a rare commodity. Toei Shinyaku is the sole company in the world that sells it.\n<\/p>\n

\nToei Shinyaku Co.,Ltd.<\/b>\n<\/p>\n

\nEstablished in 1973, Toei Shinyaku is a Japanese manufacturer that specializes in R&D activities, as well as the manufacture and sale of Agaricus KA21. Toei Shinyaku has conducted research on Agaricus KA21 for over 25 years and presented 32 international papers on its findings; making it the company with the greatest research results out of all Japanese Agaricus blazei<\/i> manufacturers. Toei Shinyaku discloses evidence supporting its product, Agaricus KA21, on its official homepage. Details include the safety of human clinical trials of Agaricus KA21, ability to strengthen the immune system, alleviate fatigue, improve hair loss and gray hair, and prevent fungal infection. Data also includes the effect of Agaricus KA21 found through trials on mice; such as reducing side effects of anticancer drugs, hair growth benefits, and enhanced wound healing.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nToei Shinyaku Co.,Ltd.
\n
Akitomo Motoi
\n
info@toeishinyaku.jp<\/a>
Cross-Border EC website: www.toeishinyaku.jp<\/a>
For business inquiry including wholesales and OEM: www.agaricus.co.jp<\/a>
Main Products: Akkerman Slim etc.\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data concerning the mechanism by which Agaricus blazei KA21 enhances immunity, its immunological enhancement effect as confirmed by human clinical trials, and candida and other types of fungal infection. Agaricus blazei KA21 product has been sold in the Japanese market as a supplement for the immune … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47228","6":"format-standard","7":"category-industry"},"yoast_head":"\nDisclosure of data on Agaricus blazei mushroom, KA21's immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Disclosure of data on Agaricus blazei mushroom, KA21's immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data concerning the mechanism by which Agaricus blazei KA21 enhances immunity, its immunological enhancement effect as confirmed by human clinical trials, and candida and other types of fungal infection. Agaricus blazei KA21 product has been sold in the Japanese market as a supplement for the immune ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-12T05:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220807005053\/en\/1537303\/21\/org_logo20210316171002i00ZYh.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku\",\"datePublished\":\"2022-08-12T05:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/\"},\"wordCount\":414,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220807005053\\\/en\\\/1537303\\\/21\\\/org_logo20210316171002i00ZYh.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/\",\"name\":\"Disclosure of data on Agaricus blazei mushroom, KA21's immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220807005053\\\/en\\\/1537303\\\/21\\\/org_logo20210316171002i00ZYh.jpg\",\"datePublished\":\"2022-08-12T05:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220807005053\\\/en\\\/1537303\\\/21\\\/org_logo20210316171002i00ZYh.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220807005053\\\/en\\\/1537303\\\/21\\\/org_logo20210316171002i00ZYh.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Disclosure of data on Agaricus blazei mushroom, KA21's immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/","og_locale":"en_US","og_type":"article","og_title":"Disclosure of data on Agaricus blazei mushroom, KA21's immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku - Pharma Trend","og_description":"TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data concerning the mechanism by which Agaricus blazei KA21 enhances immunity, its immunological enhancement effect as confirmed by human clinical trials, and candida and other types of fungal infection. Agaricus blazei KA21 product has been sold in the Japanese market as a supplement for the immune ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-12T05:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220807005053\/en\/1537303\/21\/org_logo20210316171002i00ZYh.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku","datePublished":"2022-08-12T05:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/"},"wordCount":414,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220807005053\/en\/1537303\/21\/org_logo20210316171002i00ZYh.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/","url":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/","name":"Disclosure of data on Agaricus blazei mushroom, KA21's immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220807005053\/en\/1537303\/21\/org_logo20210316171002i00ZYh.jpg","datePublished":"2022-08-12T05:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220807005053\/en\/1537303\/21\/org_logo20210316171002i00ZYh.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220807005053\/en\/1537303\/21\/org_logo20210316171002i00ZYh.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/disclosure-of-data-on-agaricus-blazei-mushroom-ka21s-immunity-enhancing-mechanism-immunological-enhancement-effect-confirmed-by-human-clinical-trials-and-candida-and-other-types-of-fungal-infectio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47228"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47228\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}